基因组信息化风险评估在预测痴呆症结果中的作用
Shea J Andrews1, Caroline Jonson2,3,4, Brian Fulton-Howard5
1Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, USA.
medRxiv : the preprint server for health sciences
|June 21, 2024
概括
将遗传和临床因素整合到痴呆风险报告中,可以增强理解和个性化大脑健康策略. 综合风险评估有效预测痴呆症,更多的指标导致风险明显增加.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 公共卫生 公共卫生
背景情况:
- 将遗传和临床风险因素整合到基因组信息化的痴呆风险报告中,可以提高患者对个人风险的理解.
- 这有助于制定个性化策略,促进大脑健康.
研究的目的:
- 开发基因组信息化风险评估,包括家族病史,遗传和临床风险因素.
- 评估本风险评估对事件痴呆症的预测能力.
主要方法:
- 一项纵向研究分析了两组临床病例控制队伍 (1994-2023) 的数据,采用全基因组测序.
- 参与者是老年人 (55岁以上) 在基线没有痴呆症.
- 添加分数结合了修改的心血管风险因素,衰老和痴呆症发病率风险分数 (mCAIDE),家族史,APOE基因型和AD多基因风险分数 (AD-PRS).
主要成果:
- 包括3,429名参与者 (75 ± 7岁);751人患有痴呆症.
- 高风险指标包括家庭病史 (56%),APOE*ε4 (36%),高mCAIDE (34%) 和高AD-PRS (11%).
- 1-4个风险指标的存在与1.72倍至12.15倍的痴呆风险增加有关,显示了剂量-反应关系.
结论:
- 记忆和衰老诊所的大多数参与者至少有一个痴呆症高风险指标.
- 更多的风险指标与发生性痴呆的风险增加相关,突显了全面风险评估的有用性.
相关概念视频
Genome-wide Association Studies-GWAS
13.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.3K
Human Genetics
557
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
557
Alzheimer's Disease: Overview
462
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
462
Dementia
110
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
110
Genetic Screens
4.9K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.9K


